Digital Health Literacy and Oocyte Cryopreservation Among Women With Gynecological Cancer
NCT07701252
Behavior, Digital Health Literacy
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT Number: NCT00699400
Phase IV, prospective multicenter, observational Registry will track cycle outcomes for subjects who are thawing frozen oocytes for subsequent use through in vitro fertilization (IVF) and embryo transfer (ET)
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Research Site, Fountain Valley, California, United States
Subjects will be enrolled at as many ART clinics that offer oocyte cryopreservation and are willing to participate in the Registry. Oocytes will be retrieved and cryopreserved from autologous or heterologous donors. When the subject decides she would like to get pregnant, oocytes will be thawed, fertilized and the resultant embryos will be transferred to the oocyte donor (for autologous use) or to another recipient (for heterologous use). The treatment regimen will be completed with births and well-baby follow-up of children at 12 months of age. Information on children will be submitted by their parents to the Investigators. Data collection for the Registry will be active for a maximum of five (5) years, including three (3) years of enrollment and two (2) additional years to complete the well-baby follow-up for all the children.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Birth of one or more live babies
Live birth rate per thawing cycle was calculated from the number of live births divided by the number of oocytes thawed less the number of embryos cryopreserved from thawed oocytes, averaged over all thawing cycles.
Time frame: Birth of one or more live babies
Oocyte Level Live Birth Rate was calculated from the total number of live births divided by the total number of oocytes thawed less the total number of embryos cryopreserved from thawed oocytes
Time frame: Birth of one or more live babies
Time frame: At cryopreservation
Time frame: At start of thawing cycle
Time frame: At time of fertilization
Number of oocytes fertilized divided by number of oocytes thawed per thawing cycle
Time frame: At time of ultrasound after embryo transfer
Implantation rate was calculated as the number of fetal sacs per transferred embryo averaged over all thawing cycles
Time frame: At time of ultrasound after embryo transfer
Number of clinical pregnancies defined as the presence of one or more fetal sacs with a heartbeat.
Time frame: Anytime after embryo transfer
Number of pregnancy outcomes reported as spontaneous abortions
EMD Serono
Industry
A Phase IV, Prospective, Multicenter, Observational Oocyte Cryopreservation Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07701252
Behavior, Digital Health Literacy
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT07543445
Assisted Reproductive Technology, Decision Aid
Taipei, Taiwan
View Trial DetailsNCT07105891
Oocyte Cryopreservation
Milan, Lombardy, Italy
View Trial DetailsNCT06853418
Oocyte Cryopreservation
Novato, California, United States
View Trial Details